Himatanthus Drasticus
Himatanthus Drasticus
Himatanthus Drasticus
www.elsevier.com/locate/bjp
Review
a r t i c l e i n f o a b s t r a c t
Article history: In order to compile the empirical use, as well as the chemical, pharmacological and biological aspects
Received 21 November 2016 of Himatanthus drasticus (Mart.) Plumel, Apocynaceae, a review was carried out by searching PubMed,
Accepted 10 October 2017 Google Scholar, Scientific Electronic Online Library, Web of Science, Science Direct, Scopus and Cochrane.
Available online 3 November 2017
For that, works in English, Spanish and Portuguese, preclinical studies and revisions, addressing chemical,
pharmacological, biological properties and popular uses, from 1994 to 2017, were used. The therapeutic
Keywords: potential of the “milk-of-janaguba” (a mixture of the latex with water) became widely known for the
Antiulcer activity
treatment of neoplasias, mainly lung and lymphatic cancer types, in the 1970s. The available literature
Gastroprotective properties
Anti-inflammatory effects
presents works related to the anti-inflammatory, antinociceptive, antitumor and gastroprotective prop-
Laticifer plants erties of the latex from bark and leaves of H. drasticus. In addition, this review presents some of our own
results with the triterpene-rich fraction from H. drasticus, attempting to clarify its action mechanisms
at the molecular level. The antinociceptive and anti-inflammatory activities of H. drasticus are proba-
bly associated with inhibitions of inflammatory mediators, as TNF-alpha, iNOS, COX-2 and NF-kB. Most
importantly, a triterpene-rich fraction also inhibited HDAC activity, and compounds with this activity
have been considered as therapeutic agents with antitumor activity. In conclusion, although the litera-
ture shows several works on species of the Himatanthus genus, including H. drasticus, dealing with some
bioactive compounds as triterpenes, translational studies focusing upon the clinical uses of this medicinal
species are still in great need.
© 2017 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction worldwide. In addition, the past decade has witnessed a huge global
interest in the use of medical plant products (Briskin, 2000).
Tropical forests are the major source of biodiversity. Brazil, that The Himathantus genus belongs to the Apocynaceae family
holds about a third of the world flora, has an undeniable wealth of which is one of the most important plant sources of pharmaco-
biologically active compounds. This wealth of the Brazilian biodi- logically active chemical compounds (DiStasi and Hiruma-Lima,
versity is reflected in the popular use of medicinal plants (Yunes 2002). The Apocynaceae family is composed of only fourteen
et al., 2001). Scientific advancements have validated the popu- species (Plumel, 1991). These species have been used in tradi-
lar use of medicinal plants as potential therapeutic alternatives tional medicine for treating bacterial, parasitic and inflammatory
(Arnous et al., 2005). Furthermore, natural bioactive compounds diseases, cancer, endocrine (diabetes), gastrointestinal and also
represent more than 50% of all drugs in therapeutics (Pan et al., central nervous system disorders and pain in general (Santos et al.,
2013) and, in this context, it is important to mention that the 2013). Some pharmacological properties were evaluated by in vitro
pharmaceutical industry is crucial for economic development and in vivo preclinical studies, as hypoglycemic (Tiong et al., 2015;
Kazeem and Ashafa, 2015; Pereira et al., 2015), analgesic and anti-
inflammatory (Sheu et al., 2009; Lucetti et al., 2010; Camargo et al.,
2013), anticonvulsant (Ya’u et al., 2008), antitumor (Almeida et al.,
∗ Corresponding author.
2004; Mousinho et al., 2011), antimicrobial (Kariba et al., 2001;
E-mail: glauce.viana@pq.cnpq.br (G.S. Viana).
https://doi.org/10.1016/j.bjp.2017.10.002
0102-695X/© 2017 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
S.C. Almeida et al. / Revista Brasileira de Farmacognosia 27 (2017) 788–793 789
Suffredini et al., 2002; Vital and Rivera, 2011; Camargo et al., 2013), anti-inflammatory, antinociceptive, antitumor and gastroprotec-
antidepressant (Camargo et al., 2013) and antiprotozoal activities tive properties of its latex, bark and leaves, but with a deficiency
(Reina et al., 2012). in relation to the central nervous system and also microbiological
The distribution of the genus is restricted to Panama and studies (Box 1).
South America and, among other species, it comprises Himatanthus Colares et al. (2008a) described cytotoxic and antinociceptive
articulatus (Vahl) Woodson (heterotypic synonym of H. sucuuba); activities for the ethanol extract of the stem bark, in classic research
Himatanthus attenuatus (Benth.) Woodson; Himatanthus bracteatus models. The cytotoxic activity was tested with an in vitro method
(A. DC.) Woodson; Himatanthus drasticus (Mart.) Plumel; Himatan- against Artemia salina, showing that the 50% lethal dose equals
thus obovatus (Müll Arg.) Woodson; Himatanthus phagedaenicus to 257 ppm. The antinociceptive effect was evaluated through the
(Mart.) Woodson; Himatanthus semilunatus Markgr; Himatanthus writhing test, induced by acetic acid and the hot plate test that
tarapotensis (Schum ex Markgr.) Plumel; Himatanthus revolutus showed an effect only in the writhing test, in a dose-dependent
(Huber) Spina & Kinoshita (Spruce) Woodson (Spina, 2016). manner (200 mg/kg and 400 mg/kg, p.o.). Additionally to this study,
Furthermore, the species H. drasticus (Mart.) Plumel is geograph- a phytochemical investigation was performed by 1 H and 13 C NMR
ically distributed in French Guiana, Suriname, Guyana and in the mass and infrared spectrometry, characterizing the presence of the
North, Midwest, Southeast and Northeast Brazil. In this last area, esterified triterpene lupeol cinnamate.
it is mainly found in the Araripe plateau (Cariri region, South of The lupeol and esters have been identified in other parts
Ceará State; Lorenzi and Matos, 2008). In Brazil, it inhabits the areas of H. drasticus. From its latex, lupeol acetate was isolated and
of Cerrado, Caatinga and the Amazon, occurring in the States of tested in models of nociception and inflammation by Lucetti et al.
Minas Gerais, Bahia, Sergipe, Alagoas, Pernambuco, Rio Grande do (2010), showing a pronounced analgesic activity in the model of
Norte, Ceará, Paraíba, Piauí, Maranhão, Pará and Roraima. In Ceará, writhings induced by acetic acid. In the formalin test, it inhibited
it is known as “janaguba”; in Minas Gerais and Bahia, as “tiborna”, the pain in both the initial (neurogenic) and the late (inflam-
“jasmim-manga” and “raivosa”; in Piaui, as “pau-de-leite”; in Rio matory) phases, possibly via the opioid system, and showed an
Grande do Norte, “joanaguba” and in the Amazon, as “sucuuba” effective antiedematogenic activity, in the model of paw edema
(Plumel, 1991; Spina, 2004). induced by carrageenan and dextran. Although the Lucetti et al.
(2010) study assigned the anti-inflammatory and antinocicep-
tive effects of the triterpene lupeol acetate isolated from the
Ethnopharmacological aspects
latex, Matos et al. (2013) attributed these effects to the protein
fraction obtained from the latex with water (“janaguba milk”),
The latex of Himatanthus drasticus is widely used in eth-
however devoid of lupeol. The protein fraction tested by the meth-
nomedicine for the prophylaxis, cure and relief of various diseases.
ods of neutrophil migration induced by carrageenan, administered
The therapeutic potential of the “milk-of-janaguba”, as the mixture
orally, showed a better effect at the lowest dose (1 mg/kg). How-
of the latex with water is commonly called, became widely known
ever, intravenously administered, the protein fraction exhibited a
for its use in the treatment of neoplasia, after medical reports of
potent and dose-dependent anti-inflammatory effect (10 mg/kg).
its effectiveness in the healing of lung and lymphatic cancers, in
The antinociceptive effect was demonstrated by inhibition of
the 1970s. Since that time, there has been a significant increase
writhings, induced by acetic acid, where the dose of 10 mg/kg
in latex extraction with therapeutic and scientific goals. In this
inhibited them by 60%, whereas in the formalin test this same
context, the city of Crato (Ceará State) has become a major extrac-
dose inhibited by 88% the paw licking, being more effective than
tion center, reaching exports of about 5000 l of “milk-of-janaguba”,
morphine (85%), in the second phase (inflammatory). These results
coordinated by the Roman Catholic Diocese of Crato and the Brazil-
suggest peripheral and central analgesic actions in the latex protein
ian Institute for the Environment and Renewable Natural Resources
fraction.
(IBAMA), for specific purposes of anticancer research (unpublished
The anti-inflammatory and antinociceptive actions of the latex
data) (Lorenzi and Matos, 2008).
protein fraction is reflected in the effects observed in experimental
In addition to the treatment of cancer, the “milk-of-janaguba”
models of arthritis, where the dose of 50 mg/kg, i.v., reduced the
has been consumed for a long time for other pathological condi-
cell influx, myeloperoxidase activity, nitric oxide levels, inflamma-
tions. Various ethnopharmacological studies register its oral use
tory cytokines (IL-1, IL-6) and edema caused by zymosan-induced
for the treatment of gastritis, ulcer, diabetes, worms, inflamma-
arthritis (Carmo, 2015). The protein fraction extracted from the
tion, heart disease, arthritis and as a laxative or, externally, for skin
latex showed an activity against the cell lines of Sarcoma 180 and
disorders and wound healing (Awaad et al., 2013; Ribeiro et al.,
Walker carcinoma 256, by the intraperitoneal route, not presenting
2014; Souza et al., 2014; Bitu et al., 2015; Saraiva et al., 2015;
orally the same effect, according to description studies of antitumor
Soares et al., 2015). The latex extraction process and preparation
and immunomodulatory activities associated with immunostimu-
of the “milk-of-janaguba” is made in a traditional manner, start-
lating properties (Mousinho et al., 2011).
ing with a longitudinal incision for the partial removal of the bark,
Furthermore, a pioneer preclinical study on antitumor activ-
employing for that a 10 × 30 cm knife. The latex exudes from the
ity of the crude methanol extract of H. drasticus leaves showed
bark and is stored with water. Subsequently, the mixture is filtered
low toxicity orally, at doses of 50, 300 and 2000 mg/kg, with
and placed into a one-liter bottle for settling and formation of a
significant tumor inhibition compared with Sarcoma 180, in a dose-
biphasic system, containing an off-white precipitate (1/4 to 1/3 of
dependent manner, compared to the control group (68% at the
the full bottle) and a slightly pink supernatant. The mixture should
dose of 400 mg/kg and 67.7% at the dose of 300 mg/kg). It also
be kept in a cold environment and is indicated for ingestion of a
presented an antitumor activity, relatively to the control animals
dose corresponding to an average cup, three times a day (Lorenzi
bearing Ehrlich carcinoma, in all doses tested. The preliminary
and Matos, 2008; Linhares and Pinheiro, 2013).
phytochemical investigations of this extract revealed the pres-
ence at a high concentration of the quercetin and rutin flavonoids,
Pharmacological properties and also found the presence of -amyrin triterpene, condensed
proanthocyanidins and leucocyanidins (Sousa, 2009; Sousa et al.,
The pharmacological potential of the H. drasticus species has 2010).
been proven in various in vivo and in vitro preclinical stud- These authors also conducted studies on the toxicity and anti-
ies, that indicate a high concentration of works related to tumor activity after the oral administration of the H. drasticus latex.
790 S.C. Almeida et al. / Revista Brasileira de Farmacognosia 27 (2017) 788–793
Chemical composition
survey. GMC was responsible for the chemical study and GSBV Leite, G.O., Penha, A.R.S., Silva, G.Q., Colares, A.V., Rodrigues, F.F.G., Costa, J.G.M.,
was responsible for the pharmacological study and writing of the Cardoso, A.L.H., Campos, A.R., 2009. Gastroprotective effectof medicinal plants
from Chapada do Araripe. Brasil. J. Young Pharm. 1, 54–56.
manuscript. Lima, M.P., Hilst, L.F., Mattana, F.V.R., Santos, C.A.M., Weffort-Santos, A.M., 2010.
Alkaloid-rich fraction of Himatanthus lancifolius contains anti-tumor agents
against leukemic cells. Braz. J. Pharm. Sci. 46, 273–280.
Conflicts of interest Linhares, J.F.P., Pinheiro, C.U.B., 2013. Caracterização do sistema de extração de
látex de janaúba (Himatanthus Willd. ExSchult.-Apocynaceae), no Município de
Alcântara, Estado do Maranhão, Brasil. Rev. Pan-Amazônica de Saúde 4, 23–31.
The authors declare no conflicts of interest. Liu, Z.-H., Li, J., Xia, J., Jiang, R., Zuo, G.-W., Li, X.-P., Chen, Y., Xiong, W., Chen, D.-L.,
2015. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors
suppressing the growth of human leukemia cells. Chemico-Biol. Int. 242,
References 227–234.
Lorenzi, H., Matos, F.J.A., 2008. Plantas medicinais no Brasil: nativas e exóticas, 2a
Almeida, S.C.X., Tese de Doutorado 2017. Estudo químico e farmacológico do látex e edição. SP Instituto Plantarum, Nova Odessa, pp. 87–88.
fração ativa isolada de Himatanthusdrasticus (Mart.) Plumel (Janaguba). Univer- Lucetti, D.L., Lucetti, E.C.P., Bandeira, M.A., Veras, H.N.H., Silva, A.H., Leal,
sidade Regional do Cariri. L.K.A.M., Lopes, A.A., Alves, V.C.C., Silva, G.S., Brito, G.A., Viana, G.B., 2010.
Almeida, L., Cintra, A.C., Veronese, E.L., Nomizo, A., Franco, J.J., Arantes, E.C., Sam- Anti-inflammatory effects and possible mechanism of action of lupeol
paio, S.V., 2004. Anticrotalic and antitumoral activities of gel filtration fractions acetate isolated from Himatanthus drasticus (Mart.) Plumel. J. Inflamm.,
of aqueous extract from Tabernaemontana catharinensis (Apocynaceae). Comp. https://doi.org/10.1186/1476-9255-7-60.
Biochem. Physiol. Part C: Toxicol. Pharmacol. 137, 19–27. Luz, H.S., Santos, A.C.G., Machado, K.R.G., 2014. Prospecção fitoquímica de Himatan-
Arnous, A.H., Santos, A.S., Beinner, R.P.C., 2005. Plantas medicinais de uso caseiro: thus drasticus Plumel (Apocynaceae), da mesorregião leste maranhense. Rev.
conhecimento popular e interesse por cultivo comunitário. Rev. EspaçoSaúde. Bras. Pl. Med. 16, 657–662.
6, 1–6. Marques, L.M., 2012. Proteínas isoladas do látex de Himatanthus drasticus (Mart.)
Awaad, A.S., El-Meligy, R.M., Soliman, G.A., 2013. Natural products in treatment of Plumel (Apocynaceae) protegem a mucosa gástrica de camundongos contra
ulcerative colitis and peptic ulcer. J. Saudi Chem. Soc. 17, 101–124. lesões induzidas por etanol: envolvimento da via NO/GMPc/KATP e da gluta-
Baggio, C.H., De Martini, O.J., de Souza, W.M., de Moraes, Santos, C.A., Torres, L.M., tiona. Dissertação de Mestrado. PPGF-UFC. Universidade Federal do Ceará.
Rieck, L., de Andrade Marques, M.C., Mesia-Vela, S., 2005. Gastroprotective Matos, M.P.V., Oliveira, R.S.B., Alencar, N.M.N., Figueiredo, I.S.T., Oliveira, J.S., Amaral,
mechanisms of indole alkaloids from Himatanthus lancifolius. Planta Med. 71, B.J.S., Nishi, B.C., Ramos, M.V., 2013. Ethnopharmacologicaluse and pharmaco-
733–738. logical activity of latex from Himatanthus drasticus (Mart.) Plumel. Int. J. Ind.
Bai, L.Y., Chiu, C.F., Chu, P.C., Lin, W.Y., Chiu, S.J., Weng, J.R., 2016. A triter- Med. Pl. 29, 1123–1131.
penoid from wild bitter gourd inhibits breast cancer cells. Sci. Rep., Moraga, C.J., 2006. Estudo do gênero Himatanthus: anatomia vegetal, fitoquímica,
https://doi.org/10.1038/srep22410. farmacologia e biotransformação. Tese de Doutorado, PPGQPN, Universidade
Baratto, L.C., Hohlemwerger, S.V.A., Guedes, M.L.S., Duarte, M.R., Santos, C.A.M., Federal do Rio de Janiro, UFRJ/NPPN.
2009. Himatanthus lancifolius(Müll. Arg.) Woodson, Apocynaceae: estudo far- Mousinho, K.C., Oliveira, C.C., Ferreira, J.R.O., Carvalho, A.A., Magalhães, H.I.F., Bez-
macobotânico de uma planta medicinal da Farmacopeia Brasileira 1a . Edição. erra, D.P., Ramos, M.V., Alves, A.P.N.N., Costa-Lotufo, L.V., Pessoa, C., Matos,
Rev. Bras. Farmacogn. 20, 651–658. M.P.V., Moraes, M.O., 2011. Antitumor effect of laticifer proteins of Himatanthus
Bitu, V.C.N., Matias, E.F.F., Lima, W.P., CostaPortelo, A., Coutinho, H.D.M., Menezes, drasticus (Mart.) Plumel – Apocynaceae. J. Ethnopharmacol. 137, 421–426.
I.R.A., 2015. Ethnopharmacological study of plants sold for therapeutic purposes Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N.,
in public markets in Northeast Brazil. J. Ethnopharmacol. 172, 265–272. Ma, D.-L., Han, Y.-F., Fong, W.-F., Ko, K.-M., 2013. Evid-Based Compl. Alt.,
Briskin, D.P., 2000. Medicinal plants and phytomedicines. Linking plant biochemistry https://doi.org/10.1155/2013/627375.
and physiology to human health. Plant. Physiol. 124, 507–514. Pereira, A.C., Pereira, A.B.D., Moreira, C.C., Botion, L.M., Lemos, V.S., Braga, F.C.,
Camargo, M.R.M., Pohlit, A.M., Carneiro, A.L.B., Neves Amorim, R.C., Rocha, L.F., Vital, Cortes, S.F., 2015. Hancornia speciosa Gomes (Apocynaceae) as a potentialanti-
M.J.S., 2013. Chemical composition, ethnopharmacology and biological activity diabeticdrug. J. Ethnopharmacol. 161, 30–35.
of Geissospermum Allemão species (Apocynaceae Juss.). Rev. Fitos 8, 73–160. Pinheiro, R.C.P., Marques, L.M., Freitas, L.B.N., Luz, P.B., Figueiredo, I.S.T., Matos, M.,
Carmo, L.D., 2015. Proteínas isoladas do látex de Himatanthus drasticus (Mart.) Souza, T., Rangel, G., Ramos, M.V., Alencar, N.M.N., 2013. Gastroprotective effects
Plumel Apocynaceae reduzem a resposta inflamatória e nociceptiva na artrite of latex from Himatanthus drasticus in models of acute gastric lesion. Faseb J. 27,
induzida por zymosan em camundongos. Dissertação de Mestrado. PPGF-UFC. 1168.6.
Universidade Federal do Ceará. Plumel, M.M., 1991. Le genre Himatanthus (Apocynaceae) révisiontaxonomique. Bol.
Chen, Y.J., Wang, W.H., Wu, W.Y., Hsu, C.C., Wei, L.R., Wang, S.F., Hsu, Y.W., Liaw, C.C., Herb. Bradeanum. 5, 1–20.
Tsai, W.C., 2017. Novel histone deacetylase inhibitor AR-42 exhibits antitumor Qian, D.Z., Wei, Y.F., Wang, X., Kato, Y., Cheng, L., Pili, R., 2007. Antitumor activity
activity in pancreatic cancer cells by affecting multiple biochemical pathways. of the histone deacetylase inhibitor MS-275 in prostate cancer models. Prostate
PLOS ONE, https://doi.org/10.1371/journal.pone.0183368. 67, 1182–1193.
Colares, A.V., Cordeiro, L.N., Costa, J.G.M., Silveira, E.R., Campos, A.R., Cardoso, A.H., Rattmann, Y.D., Terluk, M.R., Souza, W.M., Santos, C.A., Biavatti, M.W., Torres, L.B.,
2008a. Phytochemical and biological preliminary study of Himatanthus drasticus Mesia-Vela, S., Rieck, L., da Silva-Santos, J.E., Marques, M.C., 2005. Effects of alka-
(Mart.) Plumel (Janaguba). Pharmacogn. Mag. 4, 73. loids of Himatanthus lancifolius (Muell. Arg.) Woodson, Apocynaceae, on smooth
Colares, A.V., Cordeiro, L.N., Costa, J.G.M., Cardoso, A.H., Campos, A.R., 2008b. Efeito muscle responsiveness. J. Ethnopharmacol. 100, 268–275.
gastroprotetor do látex de Himatanthus drasticus (Mart.) Plumel (Janaguba). Reina, M., Ruiz-Mesia, W., López-Rodríguez, M., Ruiz-Mesia, L., González-Coloma,
Infarma 20, 34–36. A., Martínez-Díaz, R., 2012. Indole alkaloids from Geissospermum reticulatum. J.
DiStasi, L.C., Hiruma-Lima, C.A., 2002. Gentianales medicinais. In: DiStasi, L.C., Nat. Products 75, 928–934.
Hiruma-Lima, C.A. (orgs.), Plantas medicinais na Amazônia e na Mata Atlântica. Ribeiro, D.A., Oliveira, L.G.S., Macêdo, D.G., Menezes, I.R.A., Costa, J.G.M., Silva,
Editora da UNESP, São Paulo, pp. 375–385. M.A.P., Lacerda, S.R., Souza, M.M.A., 2014. Promising medicinal plants for bio-
Ferreira, J.L.P., Amaral, A.C.F., Araújo, R.B., Carvalho, J.R., Proença, C.E.B., Fraga, prospection in a Cerrado area of Chapada do Araripe, Northeastern Brazil. J.
S.A.P.M., Silva, J.R.A., 2009. Pharmacognostical comparison of three species of Ethnopharmacol. 155, 1522–1533.
Himatanthus. Int. J. Botany 5, 171–175. Santos, A.C.B., Silva, M.A.P., Santos, M.A.F., Leite, T.R., 2013. Levantamento
Figueiredo, C.S.S.E.S., Branco Santos, J.C., Castro Junior, J.A.A., Wakui, V.G., etnobotânico, químico e farmacológico de espécies de ApocynaceaeJuss. ocor-
Rodrigues, J.F.S., Arruda, M.O., Monteiro, A.S., Monteiro-Neto, V., Bom- rentes no Brasil. Rev. Bras. Pl. Med. 15, 442–458.
fim, M.R.Q., Kato, L., Nascimento da Silva, L.C., Grisotto, M.A.G., 2017. Santos, A.K.L., 2004. Contribuição ao Conhecimento Químico de Plantas do
Himatanthus drasticus leaves: chemical characterization and evaluation Nordeste do Brasil: Lippiasidoides (Cham) e Himatanthusdrasticus (Mart) Plumel.
of their antimicrobial, antibiofilm, antiproliferative activities. Molecules, Dissertação de Mestrado. PPGQO-UFC. Universidade Federal do Ceará.
https://doi.org/10.3390/molecules22060910. Saraiva, M.E., Ulisses, A.V.R.A., Ribeiro, D.A., Oliveira, L.G.S., Macêdo, D.G., Sousa,
França, W.C.D.S.C., Souza, A.C.R.L.A., Cordeiro, J.A., Cury, P.M., 2011. F.F.S., Souza, M.M.A., Menezes, I.R.A., Sampaio, E.V.S.B., 2015. Plant species as
Análise da ação da Himatanthus drasticus na progressão do câncer a therapeutic resource in areas of the savanna in the state of Pernambuco,
de pulmão, induzido por uretana em camundongos. Einstein, Northeast Brazil. J. Ethnopharmacol. 171, 141–153.
https://doi.org/10.1590/s1679-45082011ao2013. Save, S.H., Prather, P.L., Brennts, L.K., Chadalapaka, G., Jutooru, I., 2012. Unifying
Jia, W., Lu, A., Chan, K., Gustafsson, M.G., Liu, P., 2013. Translational research mechanisms of action of the anticancer activities of triterpenoids and synthetic
in complementary and alternative medicine 2014. Evid-Based Compl. Alt., analogs. Anticancer Agents Med. Chem. 12, 1211–1220.
https://doi.org/10.1155/2015/427508. Sheu, M.J., Chou, P.Y., Cheng, H.C., Wu, C.H., Huang, G.J., Wang, B.S., Huang, M.H.,
Kariba, R.M., Siboe, G.M., Dossaji, S.F., 2001. In vitro antifungal activity of Schizozy 2009. Analgesic and anti-inflammatory activities of a water extract of Trache-
giacoffaeoides Bail. (Apocynaceae) extracts. J. Ethnopharmacol. 74, 41–44. lospermum jasminoides (Apocynaceae). J. Ethnopharmacol. 126, 332–338.
Kazeem, M.I., Ashafa, A.O.T., 2015. Inhibitory effect of Alstonia boonei (Apocynaceae) Soares, F., Fraga, A., Neves, J., Romero, N., Bandeira, M., 2015. Ethnopharmacological
leaf extracts on key enzymes linked to diabetes mellitus. South Afr. J. Bot. 98, and ethnobotanical study of Himatanthus drasticus (Mart.) Plumel (janaguba).
182-182. Rev. Bras. Pl. Med. 17, 900–908.
Lee, Y.-P., Tsai, W.-C., Ko, C.-J., Rao, Y.K., Yang, C.-R., Chen, D.-R., Yang, M.-H., Yang, Sousa, E.L., 2009. Avaliação da atividade antitumoral de Himatanthus drasticus
C.-C., Tzeng, Y.-M., 2012. Anticancer effects of eleven triterpenoids derived from (Mart.) Plumel Apocynaceae (Janaguba). Dissertação de Mestrado. CCS-UFPE.
Antrodia camphorata. Anticancer Res. 21, 2727–2734. Universidade Federal de Pernambuco.
S.C. Almeida et al. / Revista Brasileira de Farmacognosia 27 (2017) 788–793 793
Sousa, E.L., Grangeiro, A.R.S., Bastos, I.V.G.A., Rodrigues, G.C.R., Anjos, F.B.R., Souza, Tran, K., Risingsong, R., Royce, D.B., Williams, C.R., Sporn, M.B., Pioli, P.A., Gediya, L.K.,
I.A., Sousa, C.E.L., 2010. Antitumor activity of leaves of Himatanthus drasticus Njar, V.C., Liby, K.T., 2013. The combination of the histone deacetylase inhibitor
(Mart.) Plumel-Apocynaceae (janaguba) in the treatment of Sarcoma 180 tumor. vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models
Braz. J. Pharm. Sci. 46, 199–203. of cancer. Carcinogenesis 34, 199–210.
Souza, R.K.D., Silva, M.A.P., Menezes, I.R.A., Ribeiro, D.A., Bezerra, L.R., Souza, M.M.A., Tiong, S.H., Looi, C.Y., Arya, A., Wong, W.F., Hazni, H., Mustafa, M.R., Awang, K., 2015.
2014. Ethnopharmacology of medicinal plants of carrasco, Northeastern Brazil. Vindogentianine, a hypoglycemic alkaloid from Catharanthus roseus (L.) G. Don
J. Ethnopharmacol. 157, 99–104. (Apocynaceae). Fitoterapia 102, 182–188.
Souza, T.F.G., 2015. Modulação da resposta inflamatória e aceleração da cicatrização Tundis, R., Loizzo, M.R., Menichini, F., Statti, G.A., Menichini, F., 2008. Biological and
de feridas cutâneas experimentais pelas proteínas isoladas do látex de pharmacological activities of iridoids: recent developments. Mini. Rev. Med.
Himatanthus drasticus Mart. (PLUMEL). Dissertação de Mestrado. PPGF-UFC. Uni- Chem. 8, 399–420.
versidade Federal do Ceará. Vital, P.G., Rivera, W.L., 2011. Antimicrobial activity, cytotoxicity, and phytochemical
Spina, A.P., 2004. Estudos taxonômico, micro-morfológico e fitogenético do gênero screening of Voacanga globosa (Blanco) Merr. leaf extract (Apocynaceae). Asian
Himatanthus Wild. Ex. Schult. (Apocynaceae: Rauvolfioidae-Plumerieae). Tese Pacific J. Trop. Med. 4, 824–828.
de Doutorado. Universidade Estadual de Campinas. Ya’u, J., Yaro, A.H., Abubakar, M.S., Anuka, J.A., Hussaini, I.M., 2008. Anticonvulsant
Spina, A.P., 2016. Himatanthus in Flora do Brasil 2020 em construção. activity of Carissa edulis (Vahl) (Apocynaceae) root bark extract. J. Ethnophar-
Jardim Botânico do Rio de Janeiro, Available from: http://floradobrasil. macol. 120, 255–258.
jbrj.gov.br/reflora/floradobrasil/FB4619 (accessed 07.08.16). Yunes, R.A., Pedrosa, R.C., Fechinel-Filho, V., 2001. Fármacos e fitoterápicos: a neces-
Suffredini, I.B., Bacchi, E.M., Sakuda, T.M.K., Ohara, M.T., Younes, R.N., Varella, A.D., sidade do desenvolvimento da indústria e fitoterápicos e fitofármacos no Brasil.
2002. Antibacterial activity of Apocynaceae extracts and MIC of Tabernaemon- Quím. Nova 24, 147–152.
tana angulata stem organic extract. Rev. Bras. Ciênc. Farm. 38, 89–94.